Molecular and Morphologic Characterization of Circulating Endothelial Cells (CEC)
Comprehensive Molecular and Morphologic Characterization of Circulating Endothelial Cells
Sponsor: Scripps Translational Science Institute
Listed as NCT01005485, this observational or N/A phase trial focuses on Acute Myocardial Infarction and remains ongoing. Sponsored by Scripps Translational Science Institute, it has been updated 14 times since 2010, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
14 versions recorded-
Feb 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Dec 2021 — Jul 2024 [monthly]
Active Not Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Active Not Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
May 2019 — Nov 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Scripps Translational Science Institute
For direct contact, visit the study record on ClinicalTrials.gov .